206 related articles for article (PubMed ID: 27038363)
1. Five-year experience with Ustekinumab for psoriasis: real-life data of a single centre.
Vergou T; Moustou AE; Antoniou C
J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):e40-e41. PubMed ID: 27038363
[No Abstract] [Full Text] [Related]
2. Ustekinumab as therapy for psoriasis in a 2-year-old girl.
Min MS; Shroff A; Rose S; Lebwohl M; Guttman-Yassky E
J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e109-e110. PubMed ID: 26377248
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period.
Megna M; Napolitano M; Balato N; Monfrecola G; Villani A; Ayala F; Balato A
Clin Exp Dermatol; 2016 Jul; 41(5):564-6. PubMed ID: 27028505
[No Abstract] [Full Text] [Related]
4. Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysis.
Pescitelli L; Dini V; Gisondi P; Loconsole F; Piaserico S; Piccirillo A; Stinco G; Errichetti E; Talamonti M; Tripo L; Volpi W; Prignano F
J Dermatol Sci; 2015 May; 78(2):149-51. PubMed ID: 25681953
[No Abstract] [Full Text] [Related]
5. Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection.
Saeki H; Ito T; Hayashi M; Fukuchi O; Umezawa Y; Nobeyama Y; Teruya K; Nakagawa H
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1653-5. PubMed ID: 24754476
[No Abstract] [Full Text] [Related]
6. Safety of ustekinumab in severe psoriasis with chronic hepatitis B.
Raymundo AR; Facin AP; Silva de Castro CC; Faria AR
Indian J Dermatol Venereol Leprol; 2016; 82(3):326-8. PubMed ID: 27088944
[No Abstract] [Full Text] [Related]
7. Different Responses to Ustekinumab of Two HLA-Cw6-positive Homozygous Twins with Psoriasis.
Burlando M; Cozzani E; Campisi C; Di Costanzo A; Parodi A
Acta Derm Venereol; 2016 Aug; 96(6):858-9. PubMed ID: 26714660
[No Abstract] [Full Text] [Related]
8. Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy.
Fujita Y; Shinkuma S; Nomura T; Shimizu H
Eur J Dermatol; 2016 Apr; 26(2):187-8. PubMed ID: 26643260
[No Abstract] [Full Text] [Related]
9. Brodalumab versus ustekinumab in psoriasis.
Fioranelli M; Roccia MG; Lotti T
Dermatol Ther; 2016 Sep; 29(5):298. PubMed ID: 26627075
[No Abstract] [Full Text] [Related]
10. Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis.
Prieto-Pérez R; Llamas-Velasco M; Cabaleiro T; Solano-López G; Márquez B; Román M; Ochoa D; Talegón M; Daudén E; Abad-Santos F
Pharmacogenomics; 2017 Jan; 18(2):157-164. PubMed ID: 27977334
[TBL] [Abstract][Full Text] [Related]
11. Clearance of annular pustular psoriasis with ustekinumab.
Schnabel V; Broekaert SMC; Schön MP; Mössner R
Eur J Dermatol; 2017 Jun; 27(3):296-297. PubMed ID: 28202422
[No Abstract] [Full Text] [Related]
12. Successful treatment of severe psoriasis in an adolescent with ustekinumab.
AbuHilal M; Ho N
Pediatr Dermatol; 2015; 32(3):377-80. PubMed ID: 25727845
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy during Ustekinumab Treatment for Severe Psoriasis.
Rocha K; Piccinin MC; Kalache LF; Reichert-Faria A; Silva de Castro CC
Dermatology; 2015; 231(2):103-4. PubMed ID: 25790947
[TBL] [Abstract][Full Text] [Related]
14. No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis with ustekinumab.
Rodríguez-Jiménez P; Chicharro P; Godoy A; Llamas-Velasco M; García M; Daudén E
Br J Dermatol; 2017 Sep; 177(3):862-863. PubMed ID: 28508387
[No Abstract] [Full Text] [Related]
15. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
[No Abstract] [Full Text] [Related]
16. Excellent response to ustekinumab in a 9-year-old girl with severe psoriasis.
González-Barreto RM; Rochet NM; Nevares-Pomales OW; Colón-Fontanez F
Pediatr Dermatol; 2018 Jan; 35(1):e76-e78. PubMed ID: 29205479
[TBL] [Abstract][Full Text] [Related]
17. Response of superimposed linear psoriasis to ustekinumab: A case report.
Weng HJ; Tsai TF
Indian J Dermatol Venereol Leprol; 2017; 83(3):392-396. PubMed ID: 28366906
[No Abstract] [Full Text] [Related]
18. Efficacy of ustekinumab in palmoplantar pustulosis.
Hegazy S; Konstantinou MP; Bulai Livideanu C; Tauber M; Uthurriague C; Paul C
J Eur Acad Dermatol Venereol; 2018 May; 32(5):e204-e206. PubMed ID: 29194805
[No Abstract] [Full Text] [Related]
19. Psoriasis vulgaris complicated by eosinophilic pneumonia during ustekinumab treatment.
Yashiro M; Maejima H; Taniguchi T; Katsuoka K; Kimura M; Wada M
Eur J Dermatol; 2013; 23(3):396-7. PubMed ID: 23728153
[No Abstract] [Full Text] [Related]
20. Successful treatment of ustekinumab in a psoriasis patient with human T-cell leukemia/lymphotropic virus type 1 infection.
Kazama M; Umezawa Y; Itoh M; Nobeyama Y; Ito T; Kikuchi S; Yanaba K; Asahina A; Nakagawa H; Ogasawara Y
J Dermatol; 2017 Nov; 44(11):1334-1335. PubMed ID: 27864824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
